Results 161 to 170 of about 69,322 (198)

In Vivo Assessment of a Triple Periodic Minimal Surface Based Biomimmetic Gyroid as an Implant Material in a Rabbit Tibia Model

ACS Materials Au
Pearlin Amaan Khan, Ansheed Raheem, Cheirmadurai Kalirajan, Konda Gokuldoss Prashanth, Geetha Manivasagam   +4 more
doaj   +1 more source

Treating Pediatric Oncology Patients: The Emerging Role of Radioligand Therapy. [PDF]

Cancers (Basel)
Laetsch TW, States LJ, Lazow MA, Chauhan A.   +3 more
europepmc   +1 more source

Nanotechnology in oncology: advances in biosynthesis, drug delivery, and theranostics

Mohamed Ammar, Rania S. Ali, Naira Ali Abd Elaziz, Heba Habib, Farhat Abbas, Mohamed Taha Yassin, Khalid Maniah, Rewan Abdelaziz   +7 more
openalex   +1 more source

Synergestic Protein-Green synthesized Nanoparticles Nanosystems: A Sustainable and Safe Approach for Cancer Theranostics. [PDF]

Nanotheranostics
Washington A, Krishnakumar GS, Kumar R.
europepmc   +1 more source

Sex modulates the ApoE ε4 effect on brain tau deposition measured by 18F-AV-1451 PET in individuals with mild cognitive impairment [PDF]

, 2019
Benzinger, Tammie L.S., Duy, Phan Q., Goyal, Manu S., Liu, Min, Lu, Jie, Paranjpe, Manish D., Wang, Rongfu, Zhou, Xin, Zhou, Yun   +8 more
core   +1 more source

Multifunctional gold nanoparticles for cancer theranostics

Donald A. Fernandes
openalex   +2 more sources

Metal grafted graphene-based nanomaterials towards cancer theranostic efficacy. [PDF]

Explor Target Antitumor Ther
Gohil PH, Avashthi G.
europepmc   +1 more source

Editorial: Advances in nanomedicine: revolutionizing healthcare with nanoscale innovations. [PDF]

Front Bioeng Biotechnol
Yu K.
europepmc   +1 more source

Correction to: Guiding principles on the education and practice of theranostics. [PDF]

Eur J Nucl Med Mol Imaging
Pascual TNB, Paez D, Iagaru A, Gnanasegaran G, Lee ST, Sathekge M, Buatti JM, Giammarile F, Al-Ibraheem A, Pardo MA, Baum RP, De Bari B, Ben-Haim S, Blay JY, Brink A, Estrada-Lobato E, Fanti S, Golubic AT, Hatazawa J, Israel O, Kiess A, Knoll P, Kunikowska J, Louw L, Mariani G, Mirzaei S, Orellana P, Prior JO, Urbain JL, Vichare S, Vinjamuri S, Virgolini I, Scott AM.   +32 more
europepmc   +1 more source

Prognostic implications of [¹⁸F]FDG PET and metabolic changes in patients with advanced metastatic neuroendocrine tumors undergoing rechallenge PRRT: final results from a multicenter 10-year survival WARMTH study. [PDF]

Theranostics
Santo G, Rodrigues M, Paez D, Morozova O, Kabasakal L, Kairemo K, Grana CM, Baum RP, di Santo G, Virgolini IJ.   +9 more
europepmc   +1 more source